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Background and purpose: Assessing the proarrhythmic potential of compounds during drug development is essential.
However, reliable prediction of drug-induced torsades de pointes arrhythmia (TdP) remains elusive. Along with QT interval
prolongation, assessment of the short-term variability of the QT interval (STV(QT)) may be a good predictor of TdP. We
investigated the relative importance of IKs and IKr block in development of TdP together with correlations between QTc
interval, QT interval variability and incidence of TdP.
Experimental approach: ECGs were recorded from conscious dogs and from anaesthetized rabbits given the IKr blocker
dofetilide (DOF), the IKs blocker HMR-1556 (HMR) and their combination, intravenously. PQ, RR and QT intervals were
measured and QTc and short-term variability of RR and QT intervals calculated.
Key results: DOF increased QTc interval by 20% in dogs and 8% in rabbits. HMR increased QTc in dogs by 12 and 1.9% in
rabbits. Combination of DOFþHMR prolonged QTc by 33% in dogs, by 16% in rabbits. DOF or HMR given alone in dogs or
HMR given alone in rabbits induced no TdP. Incidence of TdP increased after DOFþHMR combinations in dogs (63%) and
following HMRþDOF (82%) and DOFþHMR combinations (71%) in rabbits. STV(QT) markedly increased only after
administration of DOFþHMR combinations in both dogs and rabbits.
Conclusion and implications: STV(QT) was markedly increased by combined pharmacological block of IKr and IKs and may be
a better predictor of subsequent TdP development than the measurement of QTc interval prolongation.
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Introduction
Numerous cardiovascular and non-cardiovascular drugs can
cause torsades de pointes (TdP) polymorphic ventricular
tachycardia that may degenerate into ventricular fibrillation
causing sudden death (for a recent review, see Fenichel et al.,
2004). TdP arrhythmia is generally considered to be a
consequence of abnormal cardiac repolarization, that is
impairment of the repolarization process often but not
necessarily associated with, or preceded by, a prolonged QT
interval. Predicting TdP in clinical settings is an extremely
difficult task since the incidence of drug-induced TdP can be
very low (1:100 000), and such events are not closely related
to obvious changes in the QT interval. Recent evidence
suggests that a prolonged QT interval cannot reliably predict
the development of TdP since the repolarization reserve may
be reduced without noticeable changes in the duration of
cardiac repolarization. The concept of repolarization reserve,
suggested by Roden (1998), refers to the multiple mechan-
isms responsible for cardiac repolarization. Loss or impaired
function of one of these mechanisms does not necessarily
lead to clinically manifest repolarization abnormalities but
makes the heart more vulnerable to arrhythmia develop-
ment (Roden, 1998; Roden and Yang, 2005; Varro´ and Papp,
2006). Accumulating evidence strongly suggests that the
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circumstances favouring TdP development may need to be
re-defined from ‘prolonged repolarization’ to the more
appropriate ‘compromised repolarization reserve’.
One of the most elegant experimental models for drug-
induced TdP is chronic atrioventricular block in dogs
(Chezalviel-Guilbert et al., 1995; Vos et al., 1995). In this
setting, the downregulation of potassium currents, particu-
larly the slow delayed rectifier potassium current (IKs) has
been demonstrated and suggested to play a vital role in
arrhythmia development (Volders et al., 1999). Decrease of
IKs itself without sympathetic stimulation does not seem to
affect repolarization in dog, rabbit and human-isolated
ventricular muscle but it has been assumed that as an
important part of the repolarization reserve it can signifi-
cantly contribute to the safety margin of repolarization
(Varro´ et al., 2000; Lengyel et al., 2001; Volders et al., 2003;
Jost et al., 2005; Abi-Gerges et al., 2006).
In the canine chronic AV block model, amiodarone, which
markedly prolonged QTc interval, did not cause substantial
increase in the incidence of TdP, and these results were
similar to observations made in humans (van Opstal et al.,
2001). In the same model, it was found that the incidence or
lack of arrhythmias correlated well with the degree of the
short-term variability (STV) of repolarization (Thomsen et al.,
2004). After interventions that led to increased STV of
repolarization, the incidence of TdP was also increased and
following interventions that resulted in no change in STV of
repolarization, the likelihood of TdP development was not
altered in spite of significant QTc prolongation (Thomsen
et al., 2004). Therefore, STV or short-term QT variability was
suggested as a better predictor for TdP than the traditional
assessment of QTc interval.
As in the dog model of chronic AV block and TdP, IKs was
markedly downregulated and the additional IKr block
resulted in a high incidence of TdP, we have set out to
investigate the effect of combined pharmacological block of
the slow (IKs) and rapid delayed rectifier potassium currents
(IKr) on the development of arrhythmias, TdP in particular,
on repolarization and STV of repolarization in conscious
dogs and in anaesthetized rabbits.
Part of this work has been recently presented in abstract
form (Lengyel et al., 2006).
Methods
The study was conducted in accordance with the standards
of the European Community Guidelines on the Care and Use
of Laboratory Animals and the protocol had been approved
by the Ethical Committee for the Protection of Animals
in Research of the Albert Szent-Gyo¨rgyi Medical Centre,
University of Szeged, Szeged, Hungary.
Conscious dogs
Beagle dogs of both sexes (10–15 kg) were used for the
experiments. The animals were allowed to accommodate to
experimental personnel and equipment, including a loosely
fitting jacket containing electrocardiogram (ECG) electrodes,
every day for a week before the commencement of the actual
studies. After a 20-min equilibration period, baseline record-
ings were obtained. The animals were then randomly
assigned to the following two groups: (i) eight dogs received
25 mg kg1 dofetilide first, followed by 1 mg kg1 HMR 1556
after a 20-min equilibration period and (ii) six dogs were
given 1 mg kg1 HMR 1556 first, followed by 25 mg kg1
dofetilide intravenously after a 20-min equilibration period.
The drugs were administered as a 5 min continuous intrave-
nous infusion (Terufusion TE-3, Terumo Europe, Leuven,
Belgium). The ECG was obtained using precordial leads and
was digitized and stored on a computer for later analysis
using National Instruments data acquisition hardware
(National Instruments, Austin, TX, USA) and SPEL Advanced
Haemosys software (v2.7, Experimetria Ltd., Budapest,
Hungary). The PQ, RR and QT intervals were measured as
the average of 30 consecutive beats (the minimum number
of beats required for the calculation of STV of an interval, see
below), and the frequency-corrected QT interval (QTc) was
calculated using a formula recommended for Beagle dogs:
QTc¼QT–(0.087*(RR1000)) (Van de Water et al., 1989;
Tattersall et al., 2006). The intervals were measured at the
following time points during the experiments: (i) 2 min
before the start of drug infusion (baseline) and (ii) 15 min
after the end of drug infusions.
Anaesthetized rabbits
Male New Zealand white rabbits (2–3 kg) were used for the
experiments. The animals were anaesthetized with thiopen-
tone (50 mg kg1 intravenously) given into the marginal vein
of the right ear. A catheter filled with isotonic saline
containing 500 IU ml1 heparin was inserted into the left
carotid artery for the measurement of arterial blood pressure.
The right jugular vein was cannulated for subsequent
intravenous drug administration. The animals were allowed
to stabilize for 20 min and baseline measurements were
taken. The first group of rabbits received 25 mg kg1 dofetilide
in a volume of 2 ml kg1 during a 5-min infusion followed by
0.1 mg kg1 HMR 1556 after a 20-min equilibration period.
The second group was administered 0.1 mg kg1 HMR 1556
followed by 25 mg kg1 dofetilide 20 min after HMR admin-
istration. The third group received 1 mg kg1 HMR 1556
followed by 25 mg kg1 dofetilide 20 min after HMR admin-
istration.
The blood pressure and the ECG (leads I–III) were
continuously recorded (at 200 Hz), digitized and stored on
a computer for analysis using National Instruments data
acquisition hardware (National Instruments) and SPEL
Advanced Haemosys software (v2.7, Experimetria Ltd.). The
PQ, RR and QT intervals were measured as the average of 30
beats (the minimum number of beats required for the
calculation of STV of an interval, see below). During the
measurement of the QT interval in anaesthetized rabbits, the
guidelines described by Farkas et al. (2004) were followed. In
animals, such as rabbits, with a significantly faster heart rate
than that of humans, QTc calculated with Bazett’s formula
does not accurately reflect the heart rate-dependent changes
in QT interval. Therefore, QTc was calculated by a formula
specifically suggested for anaesthetized rabbits by Batey and
Coker (2002) as follows: QTc¼QT–(0.704*(RR250)).
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For the determination of plasma concentrations of Kþ ,
Naþ and Cl, blood samples were collected from anaesthetized
rabbits just before drug administration.
Short-term beat-to-beat variability of the RR and QT intervals
To characterize the instability of beat-to-beat heart rate and
repolarization, Poincare´ plots of the RR and QT intervals
were constructed, where each RR and QT value is plotted
against its former value in dogs and rabbits (Figures 2a and b,
4a and b, 5a and b and 6a and b). The plots are the result of
30 consecutive interval measurements in sinus rhythm
at a given time point during the experiments. In the
case of combined IKs and IKr block where TdP commonly
occurred, the measurements were taken before the
development of TdP. The beat-to-beat STV of RR or QT
intervals was calculated using the following formula: STV¼
P
|Dnþ1Dn|(30O2)1, where D is the duration of the QT
or RR interval. The STV represents the mean orthogonal
distance to the line-of-identity on the Poincare´ plot, and this
estimation of RR and QT interval instability is based on
previous analysis of the value of qualitative and quantitative
Poincare´ plot examination (Brennan et al., 2001).
Statistical analysis
The incidence of arrhythmias (%) was compared by using the
w2-test. All other data are expressed as means7s.e.m. After
one-way analysis of variance, the groups were compared in
pairs by means of Student’s t-test. A level of Po0.05 was
considered to be statistically significant.
Drugs
HMR 1556 (Aventis Pharma, Frankfurt am Main, Germany)
was dissolved in dimethylsulphoxide (0.1%) as a stock
solution of 10 mM. Dofetilide (Gedeon Richter Ltd.,
Budapest, Hungary) was dissolved in saline as a stock
solution of 5 mM. Each stock solution was diluted immedi-
ately before use.
Results
Effect of intravenous infusions on heart rate, QT, QTc intervals
and the STV(RR) and STV(QT) in conscious dogs
To test whether intravenous infusions influenced the heart
rate, QT, QTc intervals, STV(QT) and STV(RR) in conscious
dogs, a small group of dogs (n¼4) received vehicle
intravenously during a 5-min infusion while their ECG was
continuously recorded. Intravenous vehicle administration
did not increase the RR (720.7741.4 vs 715.5732.3 ms at
baseline, P40.05), QT (265.7712.3 vs 258.3714.5 ms at
baseline, P40.05) and QTc intervals (290711.9 vs
283.1712.8 ms at baseline, P40.05) significantly in con-
scious dogs.
Vehicle administration resulted in a small but non-
significant increase in STV(QT) in conscious dogs
(7.472.16 ms after vehicle administration vs 6.571.19 ms
at baseline, P40.05). The increase in STV(R) following
intravenous vehicle infusion proved to be non-significant
(106.2720.3 ms after vehicle vs 87.6712.5 ms at baseline,
P40.05).
Effect of combined IKr and IKs block on heart rate, QT
and QTc intervals in conscious dogs
The heart rate of the animals in the two groups was not
different at baseline (8476.4 and 88711.5 beats per min,
P40.05). Administration of the IKr blocker dofetilide
(25 mg kg1) alone did not alter the RR interval (Figure 1a).
The IKs blocker HMR 1556 (1 mg kg
1) alone had a tendency
to increase the RR interval but this increase did not prove to
be statistically significant (Figure 1a). Dofetilide did not
increase the RR interval when administered after HMR 1556
injection, but HMR 1556 significantly increased the RR
interval following dofetilide infusion (Figure 1a). Figure 1b
shows that pharmacological block of IKs or IKr alone resulted
in a statistically significant QTc prolongation, calculated
with the formula suggested by Van de Water et al. (1989) in
conscious dogs, and the combination of dofetilide and HMR
1556 administered in either order further increased the QTc
interval. The corresponding QT intervals yielded similar
results: 306.4724.3 ms after 1 mg kg1 HMR 1556 and
346.7724.4 ms after 1 mg kg1 HMR 1556þ25 mg kg1 dofe-
tilide vs 260.7715.0 ms at baseline; 303.8714.2 ms after
25 mg kg1 dofetilide and 354.0720.3 ms after 25 mg kg1
dofetilideþ1 mg kg1 HMR 1556 vs 249.276.3 ms at base-
line, all Po0.05).
Effect of combined IKr and IKs block on the STV of QT
and RR intervals in conscious dogs
Figure 2a shows Poincare´ plots constructed from the QT
intervals of an individual dog that received HMR 1556
(1 mg kg1) first, followed by dofetilide (25 mg kg1).
Figure 2b illustrates the marked increase in the STV of the
QT interval (STV(QT)) in a dog receiving dofetilide
(25 mg kg1) first, followed by the IKs blocker HMR 1556
(1 mg kg1). As the individual examples (Figure 2a and b)
and grouped average data (Figure 2c and d) show, pharmaco-
logical block of IKr or IKs alone did not result in increased
STV(QT). However, combined IKr and IKs block elevated
the STV(QT) independent of the order of the administration
of dofetilide and HMR 1556 (Figure 2c and d). In the
group where HMR 1556 was administered first, the increase
of the STV(QT) did not reach significance, most probably
due to (i) the large standard deviation of STV(QT) in this
group at baseline that remained large during subsequent
drug administration (Figure 2c) and due to (ii) the
non-uniform increase in STV(QT) in the group (the
variability of the QT interval increased significantly only
in the animals later developing TdP, Figure 3b and c).
The STV of the RR interval (STV(R)) did not increase
significantly either when HMR 1556 or dofetilide
was applied alone (Figure 2e and f). Interestingly, the
variability of the RR interval increased after the combination
of the two drugs, only when dofetilide was applied first
(Figure 2f).
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Effect of combined IKr and IKs block on the incidence of TdP
in conscious dogs
The first panel of Figure 3a illustrates TdP ventricular
tachycardia induced by the combined administration of
1 mg kg1 dofetilideþ1 mg kg1 HMR 1556 in a conscious
dog. No TdP was observed after administration of either
dofetilide or HMR 1556 alone (Figure 3a). However, when
dofetilide was administered, followed by HMR 1556, five of
eight dogs exhibited TdP, when HMR 1556 was first
administered, followed by dofetilide TdP developed in
three of six animals (Figure 3a). Although the STV of the
RR interval significantly increased following dofetili-
deþHMR 1556 administration (Figure 2c), the STV(R) was
not different between animals that developed TdP from
those not exhibiting this type of arrhythmia irrespective of
what order dofetilide and HMR 1556 were administered
(Figure 3b). On the other hand, while only the combination
of dofetilideþHMR 1556 increased the overall STV(QT)
significantly, the animals with TdP had a significantly
higher STV(QT) compared to those without TdP, irrespective
of the order of dofetilide and HMR 1556 administration
(Figure 3c).
Figure 4 illustrates the increased STV(QT) in dogs with TdP
in contrast to the unchanged STV(QT) in those without TdP
after administration of dofetilide followed by HMR 1556
(1 mg kg1).
Rationale for the use of anaesthetized rabbits
Since the introduction of Carlsson’s rabbit TdP model
(Carlsson et al., 1990), the anaesthetized rabbit has been
extensively used in different in vivo proarrhythmia studies
for the assessment of the risk for arrhythmia development
associated with a compound of interest (for a recent review,
see Lawrence et al., 2005). Therefore, three sets of experi-
ments investigating the effect of pharmacological block of
IKs, IKr and their combination on instability of repolarization
and the development of TdP were also performed in
anaesthetized rabbits.
Blood pressure and plasma [Kþ ] in anaesthetized rabbits
There were no differences in blood pressure among the
three groups at baseline (Table 1) The mean arterial
Figure 1 Effect of inhibiting IKr and IKs, separately and in combination, on the RR and QTc intervals in conscious dogs. (a) IKr block by dofetilide
(25 mg kg1) did not increase the RR interval, but the IKs blocker HMR 1556 (1 mg kg
1) tended to increase the RR interval alone and in
combination with dofetilide (25 mg kg1). (b) Inhibition of IKs with HMR 1556 caused a moderate, whereas IKr block by dofetilide and combined
IKs and IKr block caused a marked QTc prolongation in conscious dogs.
#Po0.05 vs control in the same group, n¼6–8 animals in each group. IKs,
the slow component of the delayed rectifier potassium current; IKr, the rapid component of the delayed rectifier potassium current.
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blood pressure (MAP) was not altered by dofetilide
(25 mg kg1) or HMR 1556 (0.1 and 1 mg kg1) alone, but
their combination significantly decreased MAP in anaesthe-
tized rabbits (Table 1). Similar changes of the systolic and
diastolic blood pressure were observed in these animals
(Table 1).
The plasma concentration of potassium can have marked
effects on the development of TdP, therefore plasma [Kþ ]
along with [Naþ ] and [Cl] were measured and found to be:
3.670.19 mM for [Kþ ], 142.171.25 mM for [Naþ ] and
100.671.72 mM for [Cl] (n¼19) before drug administration
in anaesthetized rabbits. There were no differences in plasma
[Kþ ], [Naþ ] and [Cl] between any of the groups. These
values are in good agreement with the results of Gil et al.
(2004) showing moderate hypokalaemia in thiopentone-
anaesthetized rabbits.
Figure 2 (a and b) Representative Poincare´ plots illustrate the increase in short-term variability of the QT interval (STV(QT)) following
combined IKr and IKs inhibition in conscious dogs. Right and upward shift on this figure represents QT interval prolongation while the scatter of
data points represents QT interval variability. (c and d) Grouped data show that STV(QT) was not increased by HMR 1556 (1 mg kg1
intravenously) or dofetilide (25 mg kg1 intravenously) alone, only by their combination given in either order. (e and f) STV(R) increased only
when pharmacological inhibition of IKr preceded IKs block.
#Po0.05 vs control in the same group of conscious dogs, n¼6–8 animals in each
group. IKs, the slow component of the delayed rectifier potassium current; IKr, the rapid component of the delayed rectifier potassium current;
STV(QT), short-term variability of the QT interval; STV(R), short-term variability of the RR interval.
QT interval variability and torsades de pointes
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Effect of IKr and IKs block and their combination on heart rate
and repolarization in anaesthetized rabbits
There were no differences in heart rate between the three
groups at baseline (296714.1, 27978.1 and 27474.6 beats
per min, P40.05). The QT intervals were similar in all
groups at baseline (136.175.37, 144.474.75 and
143.976.2 ms, n¼6–11, P40.05) and the same applies to
the QTc intervals.
Figure 3 (a) Representative example of TdP in a conscious dog following the combined administration of dofetilide (25mg kg1) and HMR
1556 (1 mg kg1). Grouped data showing that only combined IKr and IKs block led to the development of TdP in conscious dogs. (b) The
STV(R) interval was not different in dogs developing TdP from those not developing TdP (TdP) following combined IKs and IKr block.
(c) Detailed analysis revealed that STV(QT) was increased only in dogs that later developed TdP (TdPþ ) following the combined administration
of HMR 1556 and dofetilide, irrespective of the order of their administration. *Po0.05 vs dofetilide group. þPo0.05 vs TdP– group, n¼6–8
animals in each group. IKs, the slow component of the delayed rectifier potassium current; IKr, the rapid component of the delayed rectifier
potassium current; STV(QT), short-term variability of the QT interval; STV(R), short-term variability of the RR interval.
Figure 4 (a) Individual Poincare´ plots showing increased STV(QT) after combined IKsþ IKr block in dogs that later developed TdP but (b) no
change in STV(QT) when TdP did not occur. IKs, the slow component of the delayed rectifier potassium current; IKr, the rapid component of the
delayed rectifier potassium current; STV(QT), short-term variability of the QT interval.
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C Lengyel et al946
British Journal of Pharmacology (2007) 151 941–951
When administered alone, neither the IKr blocker dofeti-
lide (25 mg kg1, intravenously) nor the IKs blocker HMR 1556
(0.1 mg kg1) increased the RR interval (Figure 5c). Dofetilide
significantly prolonged the QTc interval while HMR 1556
had no effect on QTc (Figure 6c). In contrast, the combina-
tion of dofetilide and HMR 1556 given in any order
significantly increased the RR interval and lengthened QTc
(Figures 5c and 6c). When administered in the higher dose
(1 mg kg1), HMR 1556 did not increase QTc in anaesthetized
rabbits (165.773.86 vs 162.575.44 ms at baseline, P40.05).
However, administration of 25 mg kg1 dofetilide 20 min
following 1 mg kg1 HMR 1556 significantly increased the
QTc interval (184.578.1 vs 162.575.44 ms at baseline,
Po0.05).
Effect of IKr and IKs block and their combination on variability
of heart rate and repolarization in anaesthetized rabbits
The first two panels of Figure 5 (a and b) show representative
examples of Poincare´ plots constructed from the RR intervals
measured before and after the administration of dofetilide,
HMR 1556 (0.1 mg kg1) and their combination. There were
no differences in the STV(R) or STV(QT) among the three
groups at baseline. In anaesthetized rabbits, no significant
increase in STV(R) was observed after IKr or IKs block alone,
but given in combination in any order, dofetilide and HMR
1556 increased the variability of heart rate (Figure 5d). To
assess the stability of repolarization Poincare´ plots, QT
intervals were also drawn for each animal. Representative
plots and grouped average data shows that IKs block did not
increase STV(QT), IKr block caused a relatively small but
significant elevation of STV(QT) and IKs and IKr combination
led to an approximately fourfold increase in STV(QT)
(Figure 6).
Application of HMR 1556 in the higher dose (1 mg kg1)
alone and in combination with dofetilide yielded similar
results in anaesthetized rabbits: neither the STV(R) nor the
STV(QT) increased following its administration alone, but
significantly increased STV(QT) and STV(R) when combined
with dofetilide (STV(QT) was 2.6470.39 and 7.5670.99 ms
vs 2.3170.25 at baseline; STV(R) was 0.8170.09 and
1.6170.28 vs 0.7670.09 ms at baseline after 1 mg kg1
HMR 1556, and following the combination of 1 mg kg1
HMR 1556þ25 mg kg1 dofetilide, respectively).
No TdP was observed after HMR 1556 administration (0.1
or 1 mg kg1). Two of seven animals exhibited TdP following
dofetilide injection, but 9 of 11 developed TdP after the
combined administration of 0.1 mg kg1 HMR 1556 and
25 mg kg1 dofetilide (Figure 6); five of seven after the
combination when dofetilide was given first; and five of six
developed TdP after 1 mg kg1 HMR 1556 and 25 mg kg1
dofetilide (data not shown). Importantly, the increase in
STV(QT) paralleled the increase in the incidence of TdP in
anaesthetized rabbits (Figure 6d and f).
Discussion
The main findings of the present study are as follows:
lengthening of repolarization by IKr block in dogs did not
evoke TdP and did not markedly increase STV(QT). Decreas-
ing the repolarization reserve alone by IKs block did not
evoke TdP and did not change STV(QT) in either conscious
dogs or in anaesthetized rabbits. However, IKr block in the
presence of decreased repolarization reserve greatly augmen-
ted the incidence of TdP and also increased STV(QT) both in
conscious dogs and anaesthetized rabbits. The elevation of
STV(QT) and incidence of TdP were correlated with each
other. Finally, the increase of STV(QT) may be partially
related to the irregularity of the cycle length.
Pharmacological block of IKs: a tool for reducing repolarization
reserve
The main goal of this study was to compromise repolariza-
tion reserve by pharmacological means that resembles its
decrease in pathological settings. Therefore, we investigated
the effect of IKs and IKr block alone and in combination on
repolarization, its beat-to-beat stability and role in the
development of TdP. For this reason, it was important to
selectively inhibit IKs and IKr without significantly affecting
other ionic currents responsible for cardiac repolarization.
For this reason, dofetilide was used to block IKr (Rasmussen
et al., 1992) and HMR 1556 was used for selective pharma-
cological block of IKs. HMR 1556 was applied since it has
Table 1 Effect of dofetilide (25 mg kg1), HMR 1556 (0.1 and 1 mg kg1) and their combination on arterial blood pressure in anaesthetized rabbits
Group Dose (mg kg1) N Arterial blood pressure (mm Hg)
Mean Systolic Diastolic
Control 7 10775.2 11974.5 9175.1
Dofetilide 0.025 7 10276.9 10874.5 8275.9
DofetilideþHMR 1556 0.025þ0.1 7 8773.9# 9474.8# 7675.4#
Control 11 10272.4 11472.8 9172.5
HMR 1556 0.1 11 10471.8 11772.4 9372.3
HMR 1556þdofetilide 0.1þ0.025 11 9173.7# 10275.1# 8173.7#
Control 6 10274.6 11673.8 8773.8
HMR 1556 1 6 10375.6 11476.1 8577.2
HMR 1556þdofetilide 1þ0.025 6 9275.7 10775.3 7375.4
Arterial blood pressure values were measured during sinus rhythm. #Po0.05 vs control values within the same group.
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been shown to be superior to chromanol 293B both in its
potency and specificity for blocking IKs (Go¨gelein et al., 2000;
Thomas et al., 2003). HMR 1556 blocked IKs with an IC50 of
10–50 nM and inhibited IKr, Ito and ICa,L only at much higher
concentrations (IC50 values between 10–30 mM) while having
no effect on IK1 in concentrations up to 50 mM in canine
ventricular myocytes (Thomas et al., 2003). The dose of HMR
1556 used in this study (0.1 and 1 mg kg1) can be expected
to correspond to a plasma concentration of the compound in
the submicromolar range similarly to that achieved by
Volders et al. (2003) in conscious dogs.
Our results are in good agreement with previous studies
suggesting that IKr block but not IKs block lengthens
ventricular repolarization markedly. IKs block did not pro-
long QTc (Lengyel et al., 2001), the action potential duration
(Lengyel et al., 2001), or monophasic action potential
duration (MAPD) in rabbits (So et al., 2006). In the present
study, neither 0.1 nor 1 mg kg1 HMR 1556 caused
a significant QTc prolongation in anaesthetized rabbits
(B1–2%). On the other hand, 1 mg kg1 HMR 1556 caused
a significant QTc prolongation in conscious dogs (B12%).
However, this amount of QTc prolongation is still relatively
small compared to the QTc prolonging effect of HMR 1556
described by Volders et al. (2003), who found large (B58%)
and significant QTc lengthening after IKs block with HMR
1556 in conscious dogs. The discrepancy between the two
studies is not fully understood. However, in the study of
Volders et al. (2003), this large increase of QTc was observed
after 3 h and with a 30 mg kg1 oral dose, which resulted in a
peak plasma concentration of 2.68 mM. This is much higher
than the IC50 of HMR 1556 to block IKs (10–50 nM).
Therefore, the possibility of HMR 1556 at such a high
concentration affecting other potassium currents cannot be
ruled out. The formation of metabolites, which may affect
repolarization following oral administration, is also possible.
In conscious dogs, we applied 1 mg kg1 intravenously and
the effect on QTc lengthening was smaller than that
observed by Volders et al. (2003) with 3 mg kg1 HMR 1556
after oral administration.
Our results suggest that the present in vivo model, where
IKs is blocked pharmacologically and the repolarization
reserve becomes severely compromised, can serve as a proper
and simple tool for testing different compounds for their
possible TdP-inducing side effects.
Figure 5 (a) Representative example of a Poincare´ plot of the RR interval from an anaesthetized rabbit treated with the IKr blocker dofetilide
(25 mg kg1 intravenously) followed by HMR 1556 (0.1 mg kg1 intravenously) and (b) from another treated with the IKs blocker HMR 1556
(0.1 mg kg1 intravenously) followed by dofetilide (25 mg kg1 intravenously). (c) Combined IKr and IKs inhibition significantly increased RR
interval and (d) the RR variability in anaesthetized rabbits. #Po0.05 vs control in the same group, n¼7–11 animals in each group. IKs, the slow
component of the delayed rectifier potassium current; IKr, the rapid component of the delayed rectifier potassium current.
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STV of the QT interval predicts TdP development
In recent years, different electrophysiological parameters
have been suggested that could be used to predict drug-
induced life-threatening arrhythmias, including TdP, both in
patients and in experimental models. Such parameters
include the prolongation of the QT and QTc intervals,
spatial inhomogeneity of repolarization or QTc dispersion
(Verduyn et al., 1997; Belardinelli et al., 2003; Kaab et al.,
2003). Since the predictive power of these parameters is
rather low, new and more sensitive methods are needed.
Figure 6 (a) Representative example of a Poincare´ plot of the QT interval from an anaesthetized rabbit after the administration of the IKr
blocker dofetilide (25 mg kg1 intravenously) followed by HMR 1556 (0.1 mg kg1 intravenously) and (b) from another after the combined
administration of the IKs blocker HMR 1556 (0.1 mg kg
1 intravenously) and dofetilide (25 mg kg1 intravenously). (c) The QTc interval was
significantly increased by dofetilide and the combination of dofetilideþHMR 1556 given in any order, but HMR 1556 alone did not lengthen
QTc. (d) STV(QT) was increased after dofetilide administration. (e and f) Combined IKr and IKs block markedly increased STV(QT) and provoked
TdP in anaesthetized rabbits. #Po0.05 vs control in the same group, *Po0.05 vs dofetilide treatment, n¼7–11 animals in each group. IKs, the
slow component of the delayed rectifier potassium current; IKr, the rapid component of the delayed rectifier potassium current; STV(QT), short-
term variability of the QT interval; STV(R), short-term variability of the RR interval.
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The results of the present study support the findings of
some earlier investigators who proposed that susceptibility
to proarrhythmia is related not only to spatial but also to
temporal dispersion of repolarization (Berger et al., 1997;
Hondeghem et al., 2001). Our results are in good agreement
with those of Thomsen et al. (2004), who found that STV of
repolarization, but not QTc changes, predicted the develop-
ment of TdP in the dog. These observations also resemble the
results of the MADIT II trial in which it was concluded that
in post-infarction patients with severe left ventricular
dysfunction, increased QT variability was associated with
increased risk for ventricular tachycardia or fibrillation (Moss
et al., 1999).
There was a difference in the STV(QT) response in
conscious dogs following the combined administration of
dofetilide and HMR 1556, that is the increase in STV(QT) was
significant only when dofetilide was administered first.
Detailed analysis of the STV(QT) data revealed that STV(QT)
increased only in dogs, which later developed TdP and this
was independent of the order of dofetilide and HMR 1556
administration.
In theory, the prolonged QT interval could inherently lead
to increased STV(QT) in experimental conditions. A recent
study by Thomsen et al. (2006) has found that, at longer
pacing cycle lengths, both the MAPD and the STV of the
MAPD were increased in anaesthetized dogs. However, when
the pacing cycle length was increased from 700 to 1200 ms,
the STV of the MAPD increased by approximately 0.5 ms. In
our conscious dogs, we did not observe such large changes in
heart rate and the calculated STV(QT) increased by more
than 100% in the dogs exhibiting TdP. Therefore, we think
that the slowing of heart rate in our study could only
minimally influence the STV(QT) increase seen after com-
bined dofetilide and HMR 1556 administration.
The cellular and ionic mechanisms responsible for the
increased STV of repolarization are unknown but they seem
to be related to the amount of available repolarization
reserve. IKs, which has been shown to be a less important
contributor to repolarization in normal settings is considered
to be a key player in determining repolarization reserve. The
pharmacological block of this current in our study and its
downregulation in the study of Thomsen et al. (2004)
strongly argues for the role of repolarization reserve and
specifically IKs in the short-term repolarization variability.
Also, short-term adaptation of repolarization to heart rate,
which may depend on intracellular calcium levels, can be a
factor since in our experiments regular rhythm was asso-
ciated with less STV(QT) than irregular rhythm. However,
the role of this latter relation is not clearly defined yet and
has not been established in earlier observations, therefore it
needs further investigation.
Limitations
Although the HMR 1556 plasma concentrations were not
determined in the present study, in our conscious dog
experiments, we observed a significant QTc prolonging effect
of intravenous HMR 1556 that is in agreement with the
results of Volders et al. (2003), where HMR 1556 was
administered orally in conscious dogs.
It is not clear how beat-to-beat variability of heart rate as
well as respiratory sinus arrhythmia influences STV(QT). A
recent study by Thomsen et al. (2007) has demonstrated no
correlation between STV(R) and the STV of repolarization in
anaesthetized dogs with chronic AV block. Our results on the
effect of combined IKs and IKr block on STV(QT) and
incidence of TdP were similar in conscious dogs with intact
adrenergic responses and marked respiratory sinus arrhyth-
mia and in anaesthetized rabbits. Anaesthetized rabbits
exhibited no respiratory sinus arrhythmia and smaller
STV(R) compared to conscious dogs.
The plasma concentration of Kþ can significantly influ-
ence the development of arrhythmias, including TdP. In our
anaesthetized rabbits, the mean [Kþ ] showed that the
animals had borderline hypokalaemia (3.670.19 mM), a
condition that favours TdP development. However, there
were no differences among groups in plasma [Kþ ] and
previous studies showed similarly low or even lower plasma
[Kþ ] in rabbits anaesthetized with thiopentone or other
compounds (Farkas and Coker, 2002; Gil et al., 2004).
Conclusions
In summary, this study further emphasizes that increased
STV(QT) precedes TdP arrhythmias and as such may be used
for the prediction of the pro-arrhythmic risk following drug
administration in addition to using conventional para-
meters. Whether this method can also be applied to
assessment of pro-arrhythmic risk in susceptible patients
needs to be elucidated by further studies. However, on the
basis of results of the present and recent studies, it is
suggested that STV of repolarization has a better predictive
value than QTc measurements in estimating the danger of
developing drug-induced arrhythmias in patients at risk.
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